CLASS II Device recall · Reported 8 Jan 2014 · FDA Enforcement Report

IntelliFill i.v recalled by Baxter Healthcare

Baxter Healthcare is recalling IntelliFill i.v. Pharmacy Compounding Device (PCD), distributed nationwide in the US. The recall was initiated on 8 Nov 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 123, 125R, 127, 129, 145, 146R, 147R, 148, 215R, 500, 501, 502, 503, 504, 505, 506, 508, 510, 511R, 512, 514, 515, 516R, 517, 518, 519, and 520.
Quantity recalled28 devices

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0607-2014
FDA event ID
66979
Recalling firm
Baxter Healthcare, Deerfield, IL
Classification
Class II
Status
Terminated
Recall initiated
8 Nov 2013
FDA classified
29 Dec 2013
Reported
8 Jan 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

8 Nov 2013Recall initiated by company
29 Dec 2013Classified by FDA+51 days
8 Jan 2014Published in enforcement report+10 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Following a retrospective review for Baxter Daytona Complaint CR-954, it was identified that the IntelliFill i.v. Pharmacy Compounding Device (PCD) (product code: IFIV) has the potential to continue to run and fill syringes with the HEPA filtration disabled.

Product as listed by the FDA

IntelliFill i.v. Pharmacy Compounding Device (PCD). Intended to fill syringes from 0.5mL up to 11.5mL using mixing instructions from its formulary to fill the orders.

Where it was distributed

Nationwide Distribution including the states of CA, CO, CT, FL, IL, LA, MA, MD, MI, NC, NE, NY, OH, OR, PA, TN, TX, and WV.

Nationwide CaliforniaColoradoConnecticutFloridaIllinoisLouisianaMassachusettsMarylandMichiganNorth CarolinaNebraskaNew YorkOhioOregonPennsylvaniaTennesseeTexasWest Virginia

Questions about this recall

Why was it recalled?

Following a retrospective review for Baxter Daytona Complaint CR-954, it was identified that the IntelliFill i.v. Pharmacy Compounding Device (PCD) (product code: IFIV) has the potential to continue to run and fill syringes with the HEPA filtration disabled.

Which lots are affected?

Lot # 123, 125R, 127, 129, 145, 146R, 147R, 148, 215R, 500, 501, 502, 503, 504, 505, 506, 508, 510, 511R, 512, 514, 515, 516R, 517, 518, 519, and 520.

Where was it sold?

Nationwide Distribution including the states of CA, CO, CT, FL, IL, LA, MA, MD, MI, NC, NE, NY, OH, OR, PA, TN, TX, and WV.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Baxter Healthcare

All 571

Other Syringes & Needles recalls

All 1,060